Biotech and the Engineering Ideal
Like the electronics start-ups, biotech execs originally saw themselves playing an engineer's game. Its founding economic rationale was to use the new science to turn the hit-or-miss process of drug discovery into a set of engineering problems applied to a business large companies avoided as unworkable-proteins.
You may also be interested in...
Pain relief product sales grew 27% and upper respiratory sales 35% for the week ended 7 March as consumers respond to COVID-19, according to Nielsen data noted in a Jefferies report on consumer health purchasing trends. Private label market share is up slightly, while OTC purchases continue primarily in conventional stores.
Managing partner Corey Goodman said venBio didn’t have trouble closing its fund, because the venture capital firm prepared its investors for an economic downturn months ago.
The US FDA has proposed moving two categories of hepatitis C diagnostics to class II from class III because they pose relatively low risk.